MBA Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
MBA Advisors's PFE Position: Q3 2026 in Review
MBA Advisors increased its Pfizer (PFE) stake by 0.08% in Q3 2026, buying an estimated $505 and bringing the position to 22,482 shares worth $641K. The position accounts for 0.21% of the portfolio, ranked #82.
MBA Advisors first reported a position in PFE in Q1 2021 and has held it in 23 quarters since. The position peaked at $1.08M in Q4 2021. 2,223 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- MBA Advisors held 22,482 shares of Pfizer worth $641K as of Q3 2026.
- MBA Advisors bought 19 Pfizer shares in Q3 2026, an estimated $505.
- Pfizer made up 0.21% of MBA Advisors's portfolio in Q3 2026, its #82 holding.
- MBA Advisors first reported a position in Pfizer in Q1 2021 and has held it in 23 quarters since.
- MBA Advisors's Pfizer position peaked at $1.08M in Q4 2021.
- 2,223 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.